Mark Ebolo Tapped to Lead Australia’s General Motors Specialty Vehicles

0
935

Mark Ebolo Tapped to Lead Australia's General Motors Specialty Vehicles


A familiar face will be leading GM’s efforts to rebound in the Australia/New Zealand market with vehicles like the C8 Corvette and Chevy Silverado.

The new managing director of General Motors Australia and New Zealand will be Marc Ebolo, who previously was managing director of the now-defunct New Zealand.

Ebolo will lead General Motors Specialty Vehicles – that will be selling the Corvette and Silverado – and Isuzu New Zealand, along with Holden service stores that will continue to offer maintenance.

“GM continues to see significant opportunity in Australia and New Zealand,” said GM senior vice president Steve Kiefer.

“We are confident that under Marc’s leadership, our GMSV business is ready to compete in key niche segments, including the Silverado light and heavy duty, as well as the C8 Corvette, coming next year.”

Ebolo said the company will work very closely in Australia and New Zealand with key partners, the soon-to-be-appointed GMSV dealers, Holden service outlets, and Walkinshaw Automotive Group and Isuzu [NZ] “to grow our businesses and theirs.”

With Ebolo’s predecessor, Kristian Aquilina, named to lead Cadillac International Operations and Cadillac Middle East, it could strengthen ties with Australia/New Zealand operations and might be a sign that Cadillac products could be added to the GMSV lineup.

“I am privileged to have worked with so many talented people who among other things have implemented a challenging but significant transformation of our business in Australia and New Zealand. Now is the right time to hand over to Marc,” said Aquilina.

“I have every confidence that under Marc’s leadership, the team will be successful well into the future.”


Source:
General Motors

Related:
GM Orders Refunds of C8 Corvette Deposits in Australia
GM Files Trademark For GMSV As Entity to Sell Vehicles in Australia Takes Shape
Mid-Engine C8 Corvette Confirmed for Australia in 2021

 



-